BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24604487)

  • 21. Optimizing veteran-centered prostate cancer survivorship care: study protocol for a randomized controlled trial.
    Skolarus TA; Metreger T; Hwang S; Kim HM; Grubb RL; Gingrich JR; Hawley ST
    Trials; 2017 Apr; 18(1):181. PubMed ID: 28420419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.
    Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
    Lancet Oncol; 2019 Feb; 20(2):267-281. PubMed ID: 30579763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of a referral and physical activity program for survivors of prostate cancer [ENGAGE]: rationale and design for a cluster randomised controlled trial.
    Livingston PM; Salmon J; Courneya KS; Gaskin CJ; Craike M; Botti M; Broadbent S; Kent B
    BMC Cancer; 2011 Jun; 11():237. PubMed ID: 21663698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preliminary results of a randomised controlled trial of an online psychological intervention to reduce distress in men treated for localised prostate cancer.
    Wootten AC; Abbott JA; Meyer D; Chisholm K; Austin DW; Klein B; McCabe M; Murphy DG; Costello AJ
    Eur Urol; 2015 Sep; 68(3):471-9. PubMed ID: 25454611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Partnering with general practitioners to optimize survivorship for patients with lymphoma: a phase II randomized controlled trial (the GOSPEL I trial).
    Chan RJ; Buhagiar S; Teleni L; Simonsen C; Turner J; Rawson C; Hart NH; Jones L; Gordon L; Joseph R; Agbejule OA; Henderson F; Rhee J; Ryan M; Carrington C; Mapp S
    Trials; 2021 Jan; 22(1):12. PubMed ID: 33407797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving depression outcomes among Australian primary care patients: protocol for a cluster randomised controlled trial.
    Carey M; Sanson-Fisher R; Zwar N; Mazza D; Meadows G; Piterman L; Waller A; Walsh J; Oldmeadow C; Deeming S; Searles A; Henskens F; Kelly B
    BMJ Open; 2020 Feb; 10(2):e032057. PubMed ID: 32047011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinician-led improvement in cancer care (CLICC)--testing a multifaceted implementation strategy to increase evidence-based prostate cancer care: phased randomised controlled trial--study protocol.
    Brown BB; Young J; Smith DP; Kneebone AB; Brooks AJ; Xhilaga M; Dominello A; O'Connell DL; Haines M
    Implement Sci; 2014 May; 9():64. PubMed ID: 24884877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of implementation strategies to influence adherence to the clinical pathway for screening, assessment and management of anxiety and depression in adult cancer patients (ADAPT CP): study protocol of a cluster randomised controlled trial.
    Butow P; Shaw J; Shepherd HL; Price M; Masya L; Kelly B; Rankin NM; Girgis A; Hack TF; Beale P; Viney R; Dhillon HM; Coll J; Kelly P; Lovell M; Grimison P; Shaw T; Luckett T; Cuddy J; White F;
    BMC Cancer; 2018 Nov; 18(1):1077. PubMed ID: 30404619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the feasibility and acceptability of couple-based psychosexual support following prostate cancer surgery: study protocol for a pilot randomised controlled trial.
    Robertson JM; Molloy GJ; Bollina PR; Kelly DM; McNeill SA; Forbat L
    Trials; 2014 May; 15():183. PubMed ID: 24886676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving sexual health in men with prostate cancer: randomised controlled trial of exercise and psychosexual therapies.
    Cormie P; Chambers SK; Newton RU; Gardiner RA; Spry N; Taaffe DR; Joseph D; Hamid MA; Chong P; Hughes D; Hamilton K; Galvão DA
    BMC Cancer; 2014 Mar; 14():199. PubMed ID: 24641777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Symptoms, unmet needs, psychological well-being and health status in survivors of prostate cancer: implications for redesigning follow-up.
    Watson E; Shinkins B; Frith E; Neal D; Hamdy F; Walter F; Weller D; Wilkinson C; Faithfull S; Wolstenholme J; Sooriakumaran P; Kastner C; Campbell C; Neal R; Butcher H; Matthews M; Perera R; Rose P
    BJU Int; 2016 Jun; 117(6B):E10-9. PubMed ID: 25818406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychosocial interventions for men with prostate cancer: a Cochrane systematic review.
    Parahoo K; McDonough S; McCaughan E; Noyes J; Semple C; Halstead EJ; Neuberger MM; Dahm P
    BJU Int; 2015 Aug; 116(2):174-83. PubMed ID: 25429987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CASPER plus (CollAborative care in Screen-Positive EldeRs with major depressive disorder): study protocol for a randomised controlled trial.
    Overend K; Lewis H; Bailey D; Bosanquet K; Chew-Graham C; Ekers D; Gascoyne S; Hems D; Holmes J; Keding A; McMillan D; Meer S; Meredith J; Mitchell N; Nutbrown S; Parrott S; Richards D; Traviss G; Trépel D; Woodhouse R; Gilbody S
    Trials; 2014 Nov; 15(1):451. PubMed ID: 25409776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can exercise suppress tumour growth in advanced prostate cancer patients with sclerotic bone metastases? A randomised, controlled study protocol examining feasibility, safety and efficacy.
    Hart NH; Newton RU; Spry NA; Taaffe DR; Chambers SK; Feeney KT; Joseph DJ; Redfern AD; Ferguson T; Galvão DA
    BMJ Open; 2017 May; 7(5):e014458. PubMed ID: 28559456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study protocol for a controlled trial of an eHealth system utilising patient reported outcome measures for personalised treatment and care: PROMPT-Care 2.0.
    Girgis A; Durcinoska I; Gerges M; Kaadan N; Arnold A; Descallar J; Delaney GP;
    BMC Cancer; 2018 Aug; 18(1):845. PubMed ID: 30139331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strengthening Care for Children (SC4C): protocol for a stepped wedge cluster randomised controlled trial of an integrated general practitioner-paediatrician model of primary care.
    Khano S; Sanci L; Woolfenden S; Zurynski Y; Dalziel K; Liaw ST; Boyle D; Freed GL; Moore C; Hodgins M; Le J; Morris TM; Germano S; Wheeler K; Lingam R; Hiscock H
    BMJ Open; 2022 Sep; 12(9):e063449. PubMed ID: 36171040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomised controlled trial protocol (GRIP study): examining the effect of involvement of a general practitioner and home care oncology nurse after a cancer diagnosis on patient reported outcomes and healthcare utilization.
    Perfors IAA; Helsper CW; Noteboom EA; van der Wall E; de Wit NJ; May AM
    BMC Cancer; 2018 Feb; 18(1):132. PubMed ID: 29402234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthetic sling or artificial urinary sphincter for men with urodynamic stress incontinence after prostate surgery: the MASTER non-inferiority RCT.
    Constable L; Abrams P; Cooper D; Kilonzo M; Cotterill N; Harding C; Drake MJ; Pardoe MN; McDonald A; Smith R; Norrie J; McCormack K; Ramsay C; Uren A; Mundy T; Glazener C; MacLennan G
    Health Technol Assess; 2022 Aug; 26(36):1-152. PubMed ID: 35972773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protocol for the CHEST Australia Trial: a phase II randomised controlled trial of an intervention to reduce time-to-consult with symptoms of lung cancer.
    Murray SR; Murchie P; Campbell N; Walter FM; Mazza D; Habgood E; Kutzer Y; Martin A; Goodall S; Barnes DJ; Emery JD
    BMJ Open; 2015 May; 5(5):e008046. PubMed ID: 25986641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.